Literature DB >> 10859458

Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative Group.

V Baldo1, A Floreani, T Menegon, G Angiolelli, R Trivello.   

Abstract

BACKGROUND: The prevalence of antibodies against hepatitis C virus (anti-HCV) increases in the general population with advancing age. Several discrepancies exist in the epidemiology of HCV, however, when selected elderly population groups are tested.
OBJECTIVE: To evaluate the HCV prevalence in two groups of elderly people living in the same geopgraphical area of northeast Italy, i.e., one including residents of a nursing home, the other including subjects living at home.
METHODS: The overall sample included 496 subjects (mean age 79.31 +/- 8.9 years); 288 were in a nursing home, and 208 were living at home. Enrollment in the latter group was based on all subjects over 65 years old listed under the public health service in the same district. The overall rate of adhesion to the study was 90%. Each subject was administered an anonymous questionnaire testing sociodemographic data and risk factors for HCV infection. Serological tests included: anti-HCV and hepatitis B virus serum markers. Multiple logistic regression analysis was performed to evaluate risk factors for anti-HCV positivity.
RESULTS: Anti-HCV positivity was found in 34 of 288 (11.8%) elderly in the nursing home and in 23 of 208 (11.1%) in the open population. When the total population was considered, females exhibited a significantly a higher prevalence of anti-HCV than males (13.4 vs. 7.5%, p < 0.05). In both males and females, the highers rate of anti-HCV prevalence was found among the 75- to 79-year-old subjects. A decline in anti-HCV prevalence was observed in the very old subjects (over 80 years of age). None of the anti-HCV-positive subjects was found to be coinfected with hepatitis B surface antigen. However, multiple logistic regression analysis identified the age group between 70 and 79 years, female gender, and positivity for antihepatitis B surface antigen and/or antihepatitis B core antigen as independent variables significantly associated with HCV prevalence.
CONCLUSIONS: The prevalence of anti-HCV proved identical among elderly people living in the nursing home or at home, suggesting that nursing homes do not represent a risk factor for HCV infections; the significant association between HCV prevalence and antihepatitis B surface antigen and/or antihepatitis B core antigen positivity supports a common route of transmission of the two viruses; these findings would suggest that there was an epidemic of HCV infection during the Second World War and in the years immediately afterwards. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859458     DOI: 10.1159/000022159

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  7 in total

1.  Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.

Authors:  Kimberly J Alvarez; Arlene Smaldone; Elaine L Larson
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

2.  Intrafamilial transmission of hepatitis C virus infection.

Authors:  Eliseo Minola; Vincenzo Baldo; Tatjana Baldovin; Renzo Trivello; Annarosa Floreani
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  High prevalence of HCV infection among the general population in a rural area of central Italy.

Authors:  A Raffaele; M Valenti; M Iovenitti; A Matani; M L Bruno; E Altobelli; A D'Alessandro; R Barnabei; B Leonardis; G Taglieri
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 4.  Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

Authors:  Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 5.  Hepatitis C in the elderly: epidemiology, natural history, and treatment.

Authors:  Ayse L Mindikoglu; Ram R Miller
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-12       Impact factor: 11.382

Review 6.  Hepatitis C Virus: Viral Quasispecies and Genotypes.

Authors:  Kyoko Tsukiyama-Kohara; Michinori Kohara
Journal:  Int J Mol Sci       Date:  2017-12-22       Impact factor: 5.923

7.  Safety and efficacy of directly-acting antiviral therapy for chronic hepatitis C virus in elderly people.

Authors:  Adriano De Santis; Daniela Maggi; Federica Lubrano Lobianco
Journal:  Aging Med (Milton)       Date:  2021-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.